Ulhys en es it fr

Ulhys Brand names, Ulhys Analogs

Ulhys Brand Names Mixture

  • No information avaliable

Ulhys Chemical_Formula


Ulhys RX_link


Ulhys fda sheet

Ulhys FDA

Ulhys msds (material safety sheet)

Ulhys Synthesis Reference

G. J. Durant et al.; U.S. Pat. 3,950,333 (1976)

Ulhys Molecular Weight

252.34 g/mol

Ulhys Melting Point

142 oC

Ulhys H2O Solubility

0.5 g/100 mL

Ulhys State


Ulhys LogP


Ulhys Dosage Forms

Tablets; Oral solution

Ulhys Indication

For the treatment and the management of acid-reflux disorders (GERD), peptic ulcer disease, heartburn, and acid indigestion

Ulhys Pharmacology

Cimetidine is a histamine H2-receptor antagonist. It reduces basal and nocturnal gastric acid secretion and a reduction in gastric volume, acidity, and amount of gastric acid released in response to stimuli including food, caffeine, insulin, betazole, or pentagastrin. It is used to treat gastrointestinal disorders such as gastric or duodenal ulcer, gastroesophageal reflux disease, and pathological hypersecretory conditions. Cimetidine inhibits many of the isoenzymes of the hepatic CYP450 enzyme system. Other actions of Cimetidine include an increase in gastric bacterial flora such as nitrate-reducing organisms.

Ulhys Absorption

Rapid 60-70%

Ulhys side effects and Toxicity

nausea, vomiting, diarrhea, increased saliva production, difficulty breathing, and a fast heartbeat.

Ulhys Patient Information

Ulhys Organisms Affected

Humans and other mammals